44
Participants
Start Date
November 30, 2006
Primary Completion Date
July 31, 2011
Study Completion Date
September 30, 2011
AMG 531
AMG 531 will be administered by SC injection once per week from Week 1 (Day 1). The maximum permitted dose of AMG 531 is 10 μg/kg. AMG 531 will be supplied as a sterile, white, preservative-free, lyophilized powder in 5 mL glass vials containing 0.6 mg of protein per vial, and a protein concentration of 0.5 mg/mL when reconstituted with 1.2 mL of sterile water for injection.
Research Site, Sapporo
Research Site, Tsukuba
Research Site, Isehara-shi
Research Site, Sagamihara
Research Site, Suita
Research Site, Chūō
Research Site, Hirakata
Research Site, Hiroshima
Research Site, Kumamoto
Research Site, Moriguchi
Research Site, Tokyo
Research Site, Tokyo
Research Site, Tokyo
Kyowa Kirin Co., Ltd.
INDUSTRY